Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
12/16/1991 | WO1991019502A1 Intercellular adhesion mediators |
12/16/1991 | CA2085475A1 Hyperosmotic solutions for isonatremic resuscitation |
12/16/1991 | CA2084888A1 Intercellular adhesion mediators |
12/16/1991 | CA2083146A1 Substituted naphthoxazines useful as dopaminergics |
12/16/1991 | CA2044811A1 Cholesterol-lowering agents and veterinary cholesterol-lowering agents |
12/16/1991 | CA2044808A1 Anti-diabetic agents and veterinary anti-diabetic agents |
12/16/1991 | CA2044802A1 Anti-herpes agents and veterinary anti-herpes agents |
12/16/1991 | CA2044700A1 Cephalosporins contening a quaternary ammomium substituted propenyl radical in third position, their preparation process, their pharmaceutical application, their compositions and the new intermediary obtained |
12/16/1991 | CA2044699A1 Derivatives of 2-aminoalkyl-5-arylalkyl-1,3-dioxanes, their preparation and their therapeutic application |
12/16/1991 | CA2044673A1 Method of diuretic treatment with 3,7-diazabicyclo[3,3,1] nonane compounds and pharmaceutical compositions therefor |
12/16/1991 | CA2044509A1 Amorphous gemfibrozil |
12/16/1991 | CA2044507A1 Gemfibrozil formulations |
12/15/1991 | WO1991019718A1 Reveromycin a, production thereof, and antitumor drug and fungicide |
12/15/1991 | WO1991019714A1 Novel oxazole derivatives, a preparation method therefor and pharmaceutical compositions containing same |
12/15/1991 | WO1991019702A1 3-aryl-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents |
12/15/1991 | WO1991019692A2 Calcium citrate malate composition |
12/15/1991 | WO1991019484A1 Injectable pharmaceutical composition |
12/15/1991 | CA2084898A1 3-aryl-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents |
12/15/1991 | CA2080340A1 Oxazole derivatives, a preparation method therefor and pharmaceutical compositions containing same |
12/15/1991 | CA2044328A1 Efomycins a.e. and g as antiinflammatory agents |
12/14/1991 | WO1991019721A1 Phosphorous produgs |
12/14/1991 | WO1991019494A1 Compositions for treating hiv-type 1 infection |
12/14/1991 | WO1991019478A1 Anti-actinic agent |
12/14/1991 | CA2085234A1 Compositions for treating hiv-type 1 infection |
12/14/1991 | CA2059641A1 Light protection compound |
12/14/1991 | CA2044423A1 Agents for treating addiction to habit-forming drugs |
12/14/1991 | CA2044405A1 N-oxyimidic acid derivatives |
12/14/1991 | CA2043463A1 Synergistic antimicrobial compositions |
12/13/1991 | WO1991019497A1 Inhibition of 5-lipoxygenase and cyclooxygenase pathway mediated diseases |
12/13/1991 | CA2085245A1 Aminosteroids for ophthalmic use |
12/13/1991 | CA2084290A1 Inhibition of 5-lipoxygenase and cyclooxygenase pathway mediated diseases |
12/12/1991 | WO1992000287A2 Analogs of carbonic anhydrase inhibitors and their use as topical iop inhibitors |
12/12/1991 | WO1991019732A1 STEROIDAL 3-ACETIC ACID DERIVATIVES AS 5α-REDUCTASE INHIBITORS |
12/12/1991 | WO1991019725A2 Heterocyclic anthracyclione and anthracycline analogs |
12/12/1991 | WO1991019498A1 Treatment of organ transplantation rejection |
12/12/1991 | WO1991019009A1 The ciliary neurotrophic factor receptor |
12/12/1991 | WO1991018969A1 Fluorinated bis(hydroxymethyl)cyclobutyl purines and pyrimidines |
12/12/1991 | WO1991018917A1 STARTING COMPOUNDS FOR THE PRODUCTION OF 10β-H STEROIDS AND PROCESS FOR PRODUCING SUCH STARTING COMPOUNDS |
12/12/1991 | WO1991018915A1 NOVEL α-GLUCOSIDASE INHIBITORS |
12/12/1991 | WO1991018906A1 [3H,7H]THIAZOLO[3,4-a]PYRIDINES WITH ANTIASTHMATIC AND ANTIINFLAMMATORY ACTIONS ON THE RESPIRATORY TRACT |
12/12/1991 | WO1991018904A1 Substituted arylsulfonamides and benzamides |
12/12/1991 | WO1991018903A1 Pyrrolopyridazine compounds |
12/12/1991 | WO1991018886A1 Compounds for the treatment of age-related memory impairment and other cognitive disorders |
12/12/1991 | WO1991018879A1 Phthalamic acids and their isomers for treating leukotriene-related diseases |
12/12/1991 | WO1991018621A1 The combination of growth hormone and insulin-like growth factor-i enhances growth |
12/12/1991 | WO1991018616A1 Composite molecular system for the contra-escalatory treatment of viral infections |
12/12/1991 | WO1991018614A1 Method for the treatment of aging or photo-damaged skin |
12/12/1991 | WO1991018611A1 Diagnosis and treatment of viral hepatitis |
12/12/1991 | WO1991018609A1 A rapid method for interrupting or attenuating poly-drug dependency syndromes |
12/12/1991 | WO1991018608A1 Use of platelet activating factor antagonists as anti-pruritic agents |
12/12/1991 | WO1991018604A1 Use of tetrahydroisoquinoline derivatives for preparing antitumoral drugs |
12/12/1991 | WO1991018603A1 1-pyperidinyl alkanoylarylsulfonamide derivatives |
12/12/1991 | WO1991018600A1 Pharmaceutical compositions for the treatment of ventricular fibrillation, impending myocardia infarction syndrome and angina containing n-(benzoyl-3 phenyl) (pyridyl-3)-3 1h,3h-pyrrolo[1,2-c] thiazolecarboxamide-7 |
12/12/1991 | WO1991018599A2 1,4-dihydropyridines for application in combatting resistance to drugs |
12/12/1991 | WO1991018598A1 Derivatives of 6-aminooctahydroindolizinetriol |
12/12/1991 | WO1991018594A1 The pharmacological use of certain cystine derivatives |
12/12/1991 | WO1991018592A1 Pharmaceutical composition containing a lithium salt and an l-phenyl isopropylamine derivative for increasing the life expectancy |
12/12/1991 | WO1991018591A1 Inhibition of viral infection |
12/12/1991 | WO1991018570A1 Therapeutically effective topical application of st1435 |
12/12/1991 | WO1991012021A3 Therapeutic agents, and intermediates for the synthesis thereof |
12/12/1991 | WO1991004754A3 Illudin analogs as anti-tumor agents |
12/12/1991 | WO1991001958A3 11β-ARYL-GONA-4,9-DIEN-3-ONES |
12/12/1991 | WO1991000081A3 Anti-malarial composition and method of use |
12/12/1991 | DE4117887A1 Use of hydrocarbon gels to prevent inhalation allergies - esp. hay fever-type atopic rhinitis, which are applied topically to inner surface of nose |
12/12/1991 | DE4018642A1 Neue salzform New salt form |
12/12/1991 | DE4018552A1 Use of K-plus channel activators - for prophylaxis of asthma and for treating other obstructive or inflammatory airway disorders |
12/12/1991 | DE4018070A1 New morpholino-urea deriv. are insect repellents |
12/12/1991 | CA2085120A1 Heterocyclic anthracyclinone and anthracycline analogs |
12/12/1991 | CA2085002A1 Treatment of organ transplantation rejection |
12/12/1991 | CA2084658A1 Analogs of carbonic anhydrase inhibitors and their use as topical iop inhibitors |
12/12/1991 | CA2084292A1 Steroidal 3-acetic acid derivatives as 5.alpha.-reductase inhibitors |
12/12/1991 | CA2083611A1 Use of platelet activating factor antagonists as anti-pruritic agents |
12/12/1991 | CA2083603A1 Diagnosis and treatment of viral hepatitis |
12/12/1991 | CA2044061A1 Epipodophyllotoxin glycosides |
12/12/1991 | CA2043861A1 Peptide oxytocin antagonists |
12/12/1991 | CA2043604A1 Pyridinylpiperazine derivatives |
12/12/1991 | CA2042868A1 Bacillus thuringiensis microbes active against nematodes, and genes encoding novel nematode-active toxins cloned from bacillus thuringiensis isolates |
12/12/1991 | CA2042526A1 Method for preventing a second heart attack employing an hmg coa reductase inhibitor |
12/11/1991 | EP0461040A1 Imidazol derivatives, their process for production, intermediates, their application as medicaments and the pharmaceutical compositions containing them |
12/11/1991 | EP0461039A1 Benzimidazole derivatives, process and intermediates for their preparation, their use as medicaments and pharmaceutical compositions containing them |
12/11/1991 | EP0461012A1 (1-Phenylpyrrolidin-2-yl)methylpiperazine derivatives, process for their preparation and their use in therapy |
12/11/1991 | EP0460924A1 Dichloroaniline compound |
12/11/1991 | EP0460912A2 Medicaments for the treatment of sexual disorder |
12/11/1991 | EP0460848A1 Stearidonic acid and/or eicosatetraenoic acid for the treatment of inflammations |
12/11/1991 | EP0460720A2 A method of extruding liposomes |
12/11/1991 | EP0460690A2 Use of phenolsulfophthaline derivatives for the treatment of osteoporosis |
12/11/1991 | EP0460622A1 Pharmaceutical preparation for the systemic treatment of toy fish and domestic fish |
12/11/1991 | EP0460488A1 Sulfur-containing heterocyclic compounds |
12/11/1991 | EP0460448A2 Use of C63-amide derivatives of 34-de(acetylglucosaminyl)-34-deoxy-teicoplanin against bacteria resistant to glycopeptide antibiotics |
12/11/1991 | EP0460418A2 Novel Dihydropyridine derivative |
12/11/1991 | EP0460358A2 Agent for treating disorders from cerebral neuro-degeneration |
12/11/1991 | EP0460232A1 Tumor cell growth inhibitor |
12/11/1991 | EP0460153A1 NEW-$g(b)-CARBOLINS, PROCESS FOR PREPARING THEM AND THEIR USE IN DRUGS |
12/11/1991 | EP0460084A1 Novel beta-methoxyacrylates, their production and use |
12/11/1991 | EP0460080A1 Orally administerable calcium supplement for cattle. |
12/11/1991 | EP0460078A1 Pharmaceutically active agents that impede amyloid formation in vivo |
12/11/1991 | EP0460072A1 Human elastase inhibitor |
12/11/1991 | EP0460058A1 Use of bactericidal/permeability increasing protein or biologically active analogs thereof for the manufacture of a medicament to treat endotoxin-associated disorders |
12/11/1991 | EP0460045A1 Nucleoside analogues |
12/11/1991 | EP0459983A1 Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1,3-benzoxazine-4-ones |